GSAGE Trademark

Trademark Overview

On Thursday, October 10, 2024, a trademark application was filed for GSAGE with the United States Patent and Trademark Office. The USPTO has given the GSAGE trademark a serial number of 98795264. The federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED as of Friday, July 18, 2025. This trademark is owned by GeneSilico Inc.. The GSAGE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing online non-downloadable computer software platform for using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software for genetic testing for medical purposes; Software as a Service (SAAS) services featuring genetic testing panels, generative artificial intelligence (AI) insights for oncology related clinical decision support, precision oncologist and patient services
gsage

General Information

Serial Number98795264
Word MarkGSAGE
Filing DateThursday, October 10, 2024
Status661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED
Status DateFriday, July 18, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Pseudo MarkGENE SAGE
Goods and ServicesProviding online non-downloadable computer software platform for using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software using generative artificial intelligence (AI) to provide clinical decision support in the fields of genomics and cancer research, testing, diagnosis and treatment; Software as a Service (SAAS) services featuring software for genetic testing for medical purposes; Software as a Service (SAAS) services featuring genetic testing panels, generative artificial intelligence (AI) insights for oncology related clinical decision support, precision oncologist and patient services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, October 10, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGeneSilico Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAustin, TX 78746

Trademark Events

Event DateEvent Description
Thursday, October 10, 2024NEW APPLICATION ENTERED
Tuesday, April 15, 2025ASSIGNED TO EXAMINER
Monday, April 21, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 21, 2025NON-FINAL ACTION WRITTEN
Monday, April 14, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, April 21, 2025NON-FINAL ACTION E-MAILED
Friday, July 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 18, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 18, 2025TEAS/EMAIL CORRESPONDENCE ENTERED

Related Keywords

gsage software services testing intelligence clinical decision support artificial generative featuring